Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunther Marsche

Showing results (11-20 of 135) with videos related to

Pageof 14
Sort By:
International Journal of Molecular Sciences|April 30, 2021
Role of Short Chain Fatty Acids and Apolipoproteins in the Regulation of Eosinophilia-Associated DiseasesEva Maria Sturm, Eva Knuplez, Gunther Marsche
International Journal of Molecular Sciences|April 30, 2021
Emerging Role of Phospholipase-Derived Cleavage Products in Regulating Eosinophil Activity: Focus on Lysophospholipids, Polyunsaturated Fatty Acids and EicosanoidsEva Knuplez, Eva Maria Sturm, Gunther Marsche
Pharmacology & Therapeutics|July 4, 2024
HDL-based therapeutics: A promising frontier in combating viral and bacterial infectionsAlankrita Rani, Julia T Stadler, Gunther Marsche
Trends in Molecular Medicine|March 2, 2024
HDL and SARS CoV-2: emerging theragnostic implicationsAlankrita Rani, Julia T Stadler, Gunther Marsche
Archives of Biochemistry and Biophysics|September 21, 2005
Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteinsErnst Malle, Gunther Marsche, Ute Panzenboeck, et al.
Pharmacology & Therapeutics|March 26, 2013
E-type prostanoid receptor 4 (EP4) in disease and therapyViktoria Konya, Gunther Marsche, Rufina Schuligoi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 31, 2007
Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoproteinGunther Marsche, Bernd Weigle, Wolfgang Sattler, et al.
Pharmacology & Therapeutics|December 19, 2012
Inflammation alters HDL composition and function: implications for HDL-raising therapiesGunther Marsche, Marcus D Saemann, Akos Heinemann, et al.
Antioxidants (Basel, Switzerland)|March 25, 2022
Understanding Myeloperoxidase-Induced Damage to HDL Structure and Function in the Vessel Wall: Implications for HDL-Based TherapiesGunther Marsche, Julia T Stadler, Julia Kargl, et al.
Progress in Lipid Research|August 10, 2014
Understanding high-density lipoprotein function in disease: recent advances in proteomics unravel the complexity of its composition and biologyRuth Birner-Gruenberger, Matthias Schittmayer, Michael Holzer, et al.
Pageof 14

Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
International Journal of Molecular Sciences|April 30, 2021
Role of Short Chain Fatty Acids and Apolipoproteins in the Regulation of Eosinophilia-Associated DiseasesEva Maria Sturm, Eva Knuplez, Gunther Marsche
International Journal of Molecular Sciences|April 30, 2021
Emerging Role of Phospholipase-Derived Cleavage Products in Regulating Eosinophil Activity: Focus on Lysophospholipids, Polyunsaturated Fatty Acids and EicosanoidsEva Knuplez, Eva Maria Sturm, Gunther Marsche
Pharmacology & Therapeutics|July 4, 2024
HDL-based therapeutics: A promising frontier in combating viral and bacterial infectionsAlankrita Rani, Julia T Stadler, Gunther Marsche
Trends in Molecular Medicine|March 2, 2024
HDL and SARS CoV-2: emerging theragnostic implicationsAlankrita Rani, Julia T Stadler, Gunther Marsche
Archives of Biochemistry and Biophysics|September 21, 2005
Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteinsErnst Malle, Gunther Marsche, Ute Panzenboeck, et al.
Pharmacology & Therapeutics|March 26, 2013
E-type prostanoid receptor 4 (EP4) in disease and therapyViktoria Konya, Gunther Marsche, Rufina Schuligoi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 31, 2007
Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoproteinGunther Marsche, Bernd Weigle, Wolfgang Sattler, et al.
Pharmacology & Therapeutics|December 19, 2012
Inflammation alters HDL composition and function: implications for HDL-raising therapiesGunther Marsche, Marcus D Saemann, Akos Heinemann, et al.
Antioxidants (Basel, Switzerland)|March 25, 2022
Understanding Myeloperoxidase-Induced Damage to HDL Structure and Function in the Vessel Wall: Implications for HDL-Based TherapiesGunther Marsche, Julia T Stadler, Julia Kargl, et al.
Progress in Lipid Research|August 10, 2014
Understanding high-density lipoprotein function in disease: recent advances in proteomics unravel the complexity of its composition and biologyRuth Birner-Gruenberger, Matthias Schittmayer, Michael Holzer, et al.
Pageof 14